# A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

> **NCT02415842** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 414 (actual)

## Conditions studied

- Immunologic Tests

## Interventions

- **OTHER:** Serum samples

## Key facts

- **NCT ID:** NCT02415842
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-26
- **Primary completion:** 2018-02-16
- **Final completion:** 2018-02-16
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2019-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415842, "A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02415842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*